Eliminating Bottlenecks: Real-Time Insights In Pharmaceutical Production

Ravi Kiran Koppichetti's work with Plant Intelligence systems highlights the integration of real-time data in pharmaceutical manufacturing, improving efficiency and regulatory compliance. His contributions lead to significant reductions in cycle times and enhanced data integrity.

In the pharmaceutical industry, or in any industry, efficiency and compliance are two forces that often pull in different directions. Stricter regulations demand meticulous data handling, while growing patient needs push manufacturers to speed up production. Sitting at the crossroads of these considerations is Ravi Kiran Koppichetti, a professional who has dedicated his career to finding solutions through technological innovations in operations.

Koppichetti has played a key role in implementing Plant Intelligence (PI) systems in pharmaceutical manufacturing. As the Product Owner for PI deployment at two major drug manufacturing plants, he has managed projects that enable organizations to collect, store, and analyze data in real-time from nearly 10,000 IoT devices. These systems have enhanced visibility and ensured adherence to strict regulatory frameworks.

In addition to his role as Product Owner, he serves as the Data Steward for PI data, further enhancing his expertise in maintaining data integrity and assuring its integrity in downstream integrations such as Analytics, Scheduling, AI, and ML solutions to improve business. His credibility in this domain is also demonstrated by his status as a Senior Member of the International Society of Automation, where he collaborates with global peers on the latest industry best practices.

Koppichetti’s projects have also extended to the implementation of Process Analytical Technology, which enables manufacturers to measure and control a process based on the Critical Quality Attributes (CQAs) of the product in real-time. His contributions are not confined to setting up systems alone but also extend to business outcomes. At one facility, the batch manufacturing cycle time decreased by 28 percent, while at another, it dropped by 32 percent. Additionally, there was a 30 percent reduction in root cause analysis time observed by automation and quality control teams after implementing Plant Intelligence.

However, the work involved several considerations. Implementing PI in regulated manufacturing settings posed notable challenges. Compliance with 21 CFR Part 11 and GMP standards required careful configuration and validation of details like audit trails, electronic signatures, and role-based access controls. System validation through IQ/OQ/PQ protocols needed strict compliance, and integrating with existing Manufacturing Execution Systems (MES) and Laboratory Information Management Systems (LIMS) was essential to synchronize data with batch records. The unchangeable PI Data Archive was crucial for data integrity, while GMP-compliant alarms ensured deviations were recorded and documented accurately. Integrating legacy equipment also posed challenges, necessitating reliable PI interfaces and data buffering, which involved both technical and strategic problem-solving.

His thought leadership goes beyond direct implementation. Koppichetti has engaged in academic and professional discussions through published works like "Convergence of Information Technology (IT) and Operations Technology (OT) in Bio-Pharmaceutical Manufacturing Industry" and "Real-Time Anomaly Detection in Biopharmaceutical Manufacturing: A Machine Learning Approach." These papers emphasize the growing importance of data-driven strategies in modern pharmaceutical manufacturing and demonstrate their capacity to connect research with practical applications.

From his perspective, the successful use of real-time insights depends on focusing on what he calls “winnable wars.” These are high-impact, low-complexity uses of Plant Intelligence that yield quick returns without getting stuck in complicated regulatory processes. Examples include real-time media analysis and regression models to cut batch failures or improve harvest predictions for yields. He stresses that companies should start with straightforward deterministic models, such as Principal Component Analysis or rules-based systems, before progressing to more advanced machine learning and deep learning. For him, the main goal is to ensure these tools fit smoothly into operator workflows, avoiding unnecessary complexity that could hinder adoption during pilot stages.

As pharmaceutical companies face increasing pressure from regulators and markets, professionals like Ravi Kiran Koppichetti show how real-time data can help meet these challenges. His career, characterized by large-scale implementations, significant business impacts, and thought leadership, reflects a broader industry shift. By leveraging data insights and addressing integration and compliance challenges, pharmaceutical manufacturing is gradually evolving from traditional methods, aiming for faster, more precise, and reliable processes.